Skip to main content

Table 1 Patients and tumor characteristics

From: Stereotactic body radiotherapy for stage I non-small-cell lung cancer using higher doses for larger tumors: results of the second study

Characteristics

Patient number

71

Age (years), range (median)

55–89 (77)

Gender, male/female

51/20

Performance status (0/1/2)

32/33/6

T stage (T1a/T1b/T2a)

24/33/14

Total dose (48 Gy/50 Gy/52 Gy)

6/51/14

Tumor location

 Center/periphery

8/63

Operability

 Operable/inoperable

24/47

 Operable (T1a/T1b/T2a)

12/8/4

 Inoperable (T1a/T1b/T2a)

12/25/10

Histology

 Adeno/squamous/NSCLC

50/14/7

  1. Adeno adenocarcinoma, squamous squamous cell carcinoma, NSCLC unclassified non-small-cell lung cancer